Approach to repair tissue defects by bonding injectable gels to native soft tissues
Inventors
DISTEFANO, Tyler J. • Iatridis, James C.
Assignees
Interested in licensing this patent?
MTEC can help explore whether this patent might be available for licensing for your application.
Abstract
Systems, methods, and kits are described for repairing a fibrocartilage defect in a subject. The fibrocartilage defect is contacted with a first composition containing an oxidized and methacrylated glycosaminoglycan to form an imine bond between the glycosaminoglycan and the fibrocartilage defect, thereby coating the fibrocartilage defect with the glycosaminoglycan. The fibrocartilage defect coated with the glycosaminoglycan is then contacted with a mixture of a pre-polymer hydrogel composition containing a first crosslinking unit that, when polymerized, is capable of bonding to methacrylate and a hydrogel polymerization initiator composition, thereby forming a hydrogel that is covalently bonded to the glycosaminoglycan through methacrylate.
Core Innovation
The invention provides a cytocompatible two-part injectable strategy for repairing fibrocartilage defects in a subject. The method first contacts the fibrocartilage defect with a first composition comprising an oxidized and methacrylated non-sulfated glycosaminoglycan, wherein the glycosaminoglycan is hyaluronic acid, to form an imine bond between the glycosaminoglycan and the fibrocartilage defect, thereby coating the fibrocartilage defect with the glycosaminoglycan.
After coating, the method contacts the defect with a pre-polymer hydrogel composition that forms an interpenetrating network (IPN) hydrogel or a single network hydrogel, where the hydrogel is covalently bonded to the glycosaminoglycan through methacrylate. The pre-polymer hydrogel composition includes a first crosslinking unit capable of bonding to methacrylate, wherein the first crosslinking unit comprises poly(ethylene glycol) diacrylate (PEGDA) having an average molecular weight of from 15 kDa to 25 kDa.
The IPN hydrogel can include a fibronectin-conjugated fibrin network within the interpenetrating network. The compositions are evaluated using dual-modified HA (HAMA Aldehyde) and compared to dual-modified chondroitin sulfate, with higher lap-shear adhesion for dual-modified HA, non-cytotoxicity to bovine annulus fibrosus cells at working concentrations, depth penetration into tissue, and covalent bonding/integration in an ex vivo bovine simulated discectomy model.
Claims Coverage
The partial content contains two independent claims. Together, they cover a two-stage method for repairing a fibrocartilage defect using imine-bond coating followed by a PEGDA-based methacrylate-bonded hydrogel, and a kit supplying the same core components in separate containers.
Imine-bond coating of a fibrocartilage defect with oxidized and methacrylated hyaluronic acid
Contacting the fibrocartilage defect with a first composition comprising an oxidized and methacrylated non-sulfated glycosaminoglycan, wherein the glycosaminoglycan is hyaluronic acid, to form an imine bond between the glycosaminoglycan and the fibrocartilage defect, thereby coating the fibrocartilage defect with the glycosaminoglycan.
Methacrylate-bonded PEGDA pre-polymer hydrogel forming an IPN or single network
Contacting the fibrocartilage defect coated with the glycosaminoglycan with a pre-polymer hydrogel composition comprising a first crosslinking unit that is capable of bonding to methacrylate, wherein the first crosslinking unit comprises poly(ethylene glycol) diacrylate (PEGDA) having an average molecular weight of from 15 kDa to 25 kDa, wherein the pre-polymer hydrogel composition forms an interpenetrating network (IPN) hydrogel or a single network hydrogel, and wherein the hydrogel is covalently bonded to the glycosaminoglycan through methacrylate.
Two-container kit with oxidized and methacrylated hyaluronic acid and a PEGDA pre-polymer hydrogel composition
A kit for repairing a fibrocartilage defect comprising a first container holding a first composition comprising an oxidized and methacrylated non-sulfated glycosaminoglycan, wherein the glycosaminoglycan is hyaluronic acid, and a second container holding a pre-polymer hydrogel composition comprising a first crosslinking unit that is capable of bonding to methacrylate, wherein the first crosslinking unit comprises poly(ethylene glycol) diacrylate (PEGDA) having an average molecular weight of from 15 kDa to 25 kDa, wherein the pre-polymer hydrogel composition forms a single network hydrogel or an interpenetrating network hydrogel (IPN).
Across the independent claims, the coverage centers on coupling an oxidized and methacrylated, non-sulfated glycosaminoglycan (hyaluronic acid) to a fibrocartilage defect via imine bond formation, followed by formation of a PEGDA-based pre-polymer hydrogel that yields an IPN or a single network and is covalently bonded to the glycosaminoglycan through methacrylate. The kit claim supplies these components in separate containers.
Stated Advantages
Higher lap-shear adhesion for dual-modified HA compared to dual-modified chondroitin sulfate.
Non-cytotoxicity to bovine annulus fibrosus cells at working concentrations.
Penetration into tissue.
Covalent bonding/integration in an ex vivo bovine simulated discectomy model.
Reduced herniation risk versus stiffer/lower MW hydrogels, with evidence of different failure modes.
Documented Applications
Repairing annulus fibrosus defects in intervertebral discs, including evaluation in an ex vivo bovine simulated discectomy model.
Assessing herniation-risk mechanics for hydrogel elasticity/mesh size in the context of intervertebral disc repair.
Interested in licensing this patent?